Health related quality of life ‐ not measured · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Leaving the study early · patients with schizophrenia
Paliperidone palmitate showed no clear difference in leaving the study early ‐ any reason Reported by trial author compared with risperidone long‐acting injection (high certainty).
1 finding from 1 review
Leaving the study early ‐ lack of efficacy Reported by trial author · patients with schizophrenia
Paliperidone palmitate probably leads to higher leaving the study early ‐ lack of efficacy Reported by trial author compared with risperidone long‐acting injection (moderate certainty).
1 finding from 1 review
Balance ( · patients with neurodegenerative disease
1 finding from 1 review
Gait Time Up and Go test and Stand‐walk‐sit test · patients with neurodegenerative disease
1 finding from 1 review
UPDRS III UPDRS scale (motor score). Scale from: 0 to 56. · patients with neurodegenerative disease
1 finding from 1 review
Hospitalization · patients submitted to transrectal prostate biopsy
Short course showed no clear difference in hospitalization compared with long course treatment (low certainty).
1 finding from 1 review
Bacteriuria · patients submitted to transrectal prostate biopsy
Short course probably leads to higher bacteriuria compared with long course treatment (moderate certainty).
1 finding from 1 review
Fever · patients submitted to transrectal prostate biopsy
Short course showed no clear difference in fever compared with long course treatment (moderate certainty).
1 finding from 1 review
UTI · patients submitted to transrectal prostate biopsy
Short course showed no clear difference in UTI compared with long course treatment (moderate certainty).
1 finding from 1 review
All‐cause mortality
HbA1c (%)
Health‐related quality of life
HbA1c (%)
All‐cause mortality
0.14 [0, 6.98]
8 studies · 2175 participants
Moderate
Peto OR 1.06 [0.62, 1.82]
14 studies · 6173 participants
Low
Early childhood caries (ECC) · Children younger than 71 months (under 6 years)
Breastfeeding for more than 12 months is associated with higher ECC prevalence (low certainty).
1 finding from 1 review
OR 1.86 [1.48, 2.35]
13 studies
Low
Early childhood caries (ECC) · Children younger than 71 months (under 6 years)
Breastfeeding for more than 24 months is associated with higher ECC prevalence (low certainty).
1 finding from 1 review
OR 2.99 [1.03, 8.67]
4 studies
Low
Early childhood caries (ECC) · Children younger than 71 months (under 6 years)
Breastfeeding for 12-24 months is associated with higher ECC prevalence (low certainty).
1 finding from 1 review
PR 3.32 [1.57, 5.07]
2 studies
Low
Early childhood caries (ECC) - incidence/risk · Children younger than 71 months (under 6 years)
Breastfeeding for 12-24 months may not increase ECC risk (low certainty).
1 finding from 1 review
RR 1.21 [0.82, 1.78]
5 studies
Low
Intervention not reported
Early childhood caries (ECC) - incidence/risk
The intervention showed no clear difference in early childhood caries (ECC) - incidence/risk; GRADE not reported.
1 finding from 1 review
RR 1.37 [0.89, 2.12]
6 studies
GRADE not reported